ID   TRPV6_RAT               Reviewed;         767 AA.
AC   Q9R186;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-2015, sequence version 2.
DT   24-JUL-2024, entry version 158.
DE   RecName: Full=Transient receptor potential cation channel subfamily V member 6;
DE            Short=TrpV6;
DE   AltName: Full=Calcium transport protein 1 {ECO:0000303|PubMed:10428857};
DE            Short=CaT1 {ECO:0000303|PubMed:11287959};
DE   AltName: Full=Epithelial calcium channel 2;
DE            Short=ECaC2;
GN   Name=Trpv6;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND TRANSPORTER ACTIVITY.
RC   STRAIN=Wistar; TISSUE=Intestine;
RX   PubMed=10428857; DOI=10.1074/jbc.274.32.22739;
RA   Peng J.-B., Chen X.Z., Berger U.V., Vassilev P.M., Tsukaguchi H.,
RA   Brown E.M., Hediger M.A.;
RT   "Molecular cloning and characterization of a channel-like transporter
RT   mediating intestinal calcium absorption.";
RL   J. Biol. Chem. 274:22739-22746(1999).
RN   [2]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TRANSPORTER ACTIVITY.
RX   PubMed=11287959; DOI=10.1038/35070596;
RA   Yue L., Peng J.B., Hediger M.A., Clapham D.E.;
RT   "CaT1 manifests the pore properties of the calcium-release-activated
RT   calcium channel.";
RL   Nature 410:705-709(2001).
RN   [3]
RP   PHOSPHORYLATION AT TYR-201 AND TYR-202, AND MUTAGENESIS OF TYR-201 AND
RP   TYR-202.
RX   PubMed=17197020; DOI=10.1016/j.ceca.2006.11.008;
RA   Sternfeld L., Anderie I., Schmid A., Al-Shaldi H., Krause E., Magg T.,
RA   Schreiner D., Hofer H.W., Schulz I.;
RT   "Identification of tyrosines in the putative regulatory site of the Ca2+
RT   channel TRPV6.";
RL   Cell Calcium 42:91-102(2007).
RN   [4] {ECO:0007744|PDB:5IWK, ECO:0007744|PDB:5IWP, ECO:0007744|PDB:5IWR, ECO:0007744|PDB:5IWT}
RP   X-RAY CRYSTALLOGRAPHY (3.25 ANGSTROMS) OF 41-709, FUNCTION, SUBUNIT,
RP   SUBCELLULAR LOCATION, TOPOLOGY, REPEATS, AND TRANSPORTER ACTIVITY.
RX   PubMed=27296226; DOI=10.1038/nature17975;
RA   Saotome K., Singh A.K., Yelshanskaya M.V., Sobolevsky A.I.;
RT   "Crystal structure of the epithelial calcium channel TRPV6.";
RL   Nature 534:506-511(2016).
RN   [5] {ECO:0007744|PDB:6BOB}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.90 ANGSTROMS) OF 41-708, SUBUNIT,
RP   SUBCELLULAR LOCATION, AND TOPOLOGY.
RX   PubMed=29258289; DOI=10.1038/nature25182;
RA   McGoldrick L.L., Singh A.K., Saotome K., Yelshanskaya M.V., Twomey E.C.,
RA   Grassucci R.A., Sobolevsky A.I.;
RT   "Opening of the human epithelial calcium channel TRPV6.";
RL   Nature 553:233-237(2018).
RN   [6] {ECO:0007744|PDB:5WO6, ECO:0007744|PDB:5WO7, ECO:0007744|PDB:5WO8, ECO:0007744|PDB:5WO9, ECO:0007744|PDB:5WOA}
RP   X-RAY CRYSTALLOGRAPHY (3.25 ANGSTROMS) OF 41-709 OF WILD-TYPE AND MUTANT
RP   GLN-495, FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, TOPOLOGY, MUTAGENESIS OF
RP   LEU-535, AND TRANSPORTER ACTIVITY.
RX   PubMed=28878326; DOI=10.1038/s41598-017-10993-9;
RA   Singh A.K., Saotome K., Sobolevsky A.I.;
RT   "Swapping of transmembrane domains in the epithelial calcium channel
RT   TRPV6.";
RL   Sci. Rep. 7:10669-10669(2017).
CC   -!- FUNCTION: Calcium selective cation channel that mediates Ca(2+) uptake
CC       in various tissues, including the intestine (PubMed:10428857,
CC       PubMed:11287959, PubMed:27296226, PubMed:28878326). Important for
CC       normal Ca(2+) ion homeostasis in the body, including bone and skin (By
CC       similarity). The channel is activated by low internal calcium level,
CC       probably including intracellular calcium store depletion, and the
CC       current exhibits an inward rectification (PubMed:10428857,
CC       PubMed:11287959, PubMed:27296226). Inactivation includes both a rapid
CC       Ca(2+)-dependent and a slower Ca(2+)-calmodulin-dependent mechanism;
CC       the latter may be regulated by phosphorylation. In vitro, is slowly
CC       inhibited by Mg(2+) in a voltage-independent manner. Heteromeric
CC       assembly with TRPV5 seems to modify channel properties. TRPV5-TRPV6
CC       heteromultimeric concatemers exhibit voltage-dependent gating (By
CC       similarity). {ECO:0000250|UniProtKB:Q91WD2,
CC       ECO:0000250|UniProtKB:Q9H1D0, ECO:0000269|PubMed:10428857,
CC       ECO:0000269|PubMed:11287959, ECO:0000269|PubMed:27296226,
CC       ECO:0000269|PubMed:28878326}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Ca(2+)(in) = Ca(2+)(out); Xref=Rhea:RHEA:29671,
CC         ChEBI:CHEBI:29108; Evidence={ECO:0000269|PubMed:10428857,
CC         ECO:0000269|PubMed:11287959, ECO:0000269|PubMed:27296226,
CC         ECO:0000269|PubMed:28878326};
CC   -!- SUBUNIT: Homotetramer (PubMed:27296226, PubMed:28878326,
CC       PubMed:29258289). Probably forms also heterotetramers with TRPV5.
CC       Interacts with TRPV5. Interacts with S100A10 and probably with the
CC       ANAX2-S100A10 heterotetramer. The interaction with S100A10 is required
CC       for the trafficking to the plasma membrane. Interacts with calmodulin.
CC       Interacts with BSPRY. Interacts with TCAF1 and TCAF2 (By similarity).
CC       {ECO:0000250|UniProtKB:Q9H1D0, ECO:0000269|PubMed:27296226,
CC       ECO:0000269|PubMed:28878326, ECO:0000269|PubMed:29258289}.
CC   -!- INTERACTION:
CC       Q9R186; Q9R186: Trpv6; NbExp=3; IntAct=EBI-7198720, EBI-7198720;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10428857,
CC       ECO:0000269|PubMed:17197020, ECO:0000269|PubMed:27296226,
CC       ECO:0000269|PubMed:28878326, ECO:0000269|PubMed:29258289}; Multi-pass
CC       membrane protein {ECO:0000269|PubMed:27296226,
CC       ECO:0000269|PubMed:28878326, ECO:0000269|PubMed:29258289}.
CC   -!- TISSUE SPECIFICITY: Expressed in duodenum, proximal jejunum, cecum, and
CC       colon. {ECO:0000269|PubMed:10428857}.
CC   -!- PTM: Glycosylated. {ECO:0000250|UniProtKB:Q91WD2,
CC       ECO:0000250|UniProtKB:Q9H1D0}.
CC   -!- PTM: Phosphorylation at Tyr-201 and Tyr-202 by SRC leads to an
CC       increased calcium influx through the channel. Probably dephosphorylated
CC       at these sites by PTPN1. {ECO:0000269|PubMed:17197020}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family. TrpV
CC       subfamily. TRPV6 sub-subfamily. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-41 is the initiator. In
CC       human and mouse, initiation starts at a conserved non-canonical ACG
CC       threonine codon decoded as Met-1 upstream of the canonical initiation
CC       at Met-41. {ECO:0000250|UniProtKB:Q91WD2,
CC       ECO:0000250|UniProtKB:Q9H1D0}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD47636.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical ACG threonine codon.; Evidence={ECO:0000250|UniProtKB:Q9H1D0};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF160798; AAD47636.1; ALT_SEQ; mRNA.
DR   RefSeq; NP_446138.1; NM_053686.1.
DR   PDB; 5IWK; X-ray; 3.25 A; A=41-709.
DR   PDB; 5IWP; X-ray; 3.65 A; A=41-709.
DR   PDB; 5IWR; X-ray; 3.85 A; A=41-709.
DR   PDB; 5IWT; X-ray; 3.80 A; A=41-709.
DR   PDB; 5WO6; X-ray; 3.31 A; A=41-708.
DR   PDB; 5WO7; X-ray; 3.25 A; A=41-709.
DR   PDB; 5WO8; X-ray; 3.40 A; A=41-709.
DR   PDB; 5WO9; X-ray; 3.70 A; A=41-709.
DR   PDB; 5WOA; X-ray; 3.90 A; A=41-709.
DR   PDB; 6BOB; EM; 3.90 A; A/B/C/D=41-708.
DR   PDB; 6D7O; X-ray; 3.45 A; A=41-709.
DR   PDB; 6D7P; X-ray; 3.37 A; A=41-709.
DR   PDB; 6D7Q; X-ray; 3.50 A; A=41-709.
DR   PDB; 6D7V; X-ray; 4.30 A; A=41-709.
DR   PDB; 6D7X; X-ray; 3.60 A; A=41-709.
DR   PDB; 6E2G; EM; 3.60 A; A/B/C/D=41-767.
DR   PDB; 7D2K; X-ray; 3.70 A; A=41-709.
DR   PDBsum; 5IWK; -.
DR   PDBsum; 5IWP; -.
DR   PDBsum; 5IWR; -.
DR   PDBsum; 5IWT; -.
DR   PDBsum; 5WO6; -.
DR   PDBsum; 5WO7; -.
DR   PDBsum; 5WO8; -.
DR   PDBsum; 5WO9; -.
DR   PDBsum; 5WOA; -.
DR   PDBsum; 6BOB; -.
DR   PDBsum; 6D7O; -.
DR   PDBsum; 6D7P; -.
DR   PDBsum; 6D7Q; -.
DR   PDBsum; 6D7V; -.
DR   PDBsum; 6D7X; -.
DR   PDBsum; 6E2G; -.
DR   PDBsum; 7D2K; -.
DR   AlphaFoldDB; Q9R186; -.
DR   EMDB; EMD-7123; -.
DR   EMDB; EMD-8962; -.
DR   SMR; Q9R186; -.
DR   DIP; DIP-47769N; -.
DR   IntAct; Q9R186; 1.
DR   MINT; Q9R186; -.
DR   STRING; 10116.ENSRNOP00000020616; -.
DR   TCDB; 1.A.4.2.7; the transient receptor potential ca2+/cation channel (trp-cc) family.
DR   GlyCosmos; Q9R186; 1 site, No reported glycans.
DR   GlyGen; Q9R186; 1 site.
DR   iPTMnet; Q9R186; -.
DR   PhosphoSitePlus; Q9R186; -.
DR   PaxDb; 10116-ENSRNOP00000020616; -.
DR   GeneID; 114246; -.
DR   KEGG; rno:114246; -.
DR   UCSC; RGD:69335; rat.
DR   AGR; RGD:69335; -.
DR   CTD; 55503; -.
DR   RGD; 69335; Trpv6.
DR   eggNOG; KOG3676; Eukaryota.
DR   InParanoid; Q9R186; -.
DR   OrthoDB; 1003028at2759; -.
DR   Reactome; R-RNO-3295583; TRP channels.
DR   PRO; PR:Q9R186; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IC:RGD.
DR   GO; GO:0034704; C:calcium channel complex; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0005227; F:calcium-activated cation channel activity; TAS:RGD.
DR   GO; GO:0005516; F:calmodulin binding; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0055074; P:calcium ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0070509; P:calcium ion import; IDA:RGD.
DR   GO; GO:0098703; P:calcium ion import across plasma membrane; IMP:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; ISO:RGD.
DR   GO; GO:0035898; P:parathyroid hormone secretion; ISO:RGD.
DR   GO; GO:0051289; P:protein homotetramerization; IPI:UniProtKB.
DR   GO; GO:0051592; P:response to calcium ion; ISS:UniProtKB.
DR   CDD; cd22192; TRPV5-6; 1.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR024862; TRPV.
DR   InterPro; IPR008344; TRPV5/TRPV6.
DR   InterPro; IPR008345; TrpV6.
DR   NCBIfam; TIGR00870; trp; 1.
DR   PANTHER; PTHR10582:SF25; TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 6; 1.
DR   PANTHER; PTHR10582; TRANSIENT RECEPTOR POTENTIAL ION CHANNEL PROTEIN; 1.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   PRINTS; PR01765; ECACCHANNEL.
DR   PRINTS; PR01766; ECACCHANNEL1.
DR   SMART; SM00248; ANK; 5.
DR   SUPFAM; SSF48403; Ankyrin repeat; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 2.
PE   1: Evidence at protein level;
KW   3D-structure; ANK repeat; Calcium; Calcium channel; Calcium transport;
KW   Calmodulin-binding; Cell membrane; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Metal-binding; Phosphoprotein; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..767
FT                   /note="Transient receptor potential cation channel
FT                   subfamily V member 6"
FT                   /id="PRO_0000215356"
FT   TOPO_DOM        1..366
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:27296226,
FT                   ECO:0000269|PubMed:28878326"
FT   TRANSMEM        367..387
FT                   /note="Helical"
FT                   /evidence="ECO:0000269|PubMed:27296226,
FT                   ECO:0000269|PubMed:28878326"
FT   TOPO_DOM        388..424
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:27296226,
FT                   ECO:0000269|PubMed:28878326"
FT   TRANSMEM        425..447
FT                   /note="Helical"
FT                   /evidence="ECO:0000269|PubMed:27296226,
FT                   ECO:0000269|PubMed:28878326"
FT   TOPO_DOM        448..462
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:27296226,
FT                   ECO:0000269|PubMed:28878326"
FT   TRANSMEM        463..482
FT                   /note="Helical"
FT                   /evidence="ECO:0000269|PubMed:27296226,
FT                   ECO:0000269|PubMed:28878326"
FT   TOPO_DOM        483..488
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:27296226,
FT                   ECO:0000269|PubMed:28878326"
FT   TRANSMEM        489..508
FT                   /note="Helical"
FT                   /evidence="ECO:0000269|PubMed:27296226,
FT                   ECO:0000269|PubMed:28878326"
FT   TOPO_DOM        509..528
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:27296226,
FT                   ECO:0000269|PubMed:28878326"
FT   TRANSMEM        529..551
FT                   /note="Helical"
FT                   /evidence="ECO:0000269|PubMed:27296226,
FT                   ECO:0000269|PubMed:28878326"
FT   TOPO_DOM        552..564
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:27296226,
FT                   ECO:0000269|PubMed:28878326"
FT   INTRAMEM        565..584
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000269|PubMed:27296226,
FT                   ECO:0000269|PubMed:28878326"
FT   TOPO_DOM        585..595
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:27296226,
FT                   ECO:0000269|PubMed:28878326"
FT   TRANSMEM        596..616
FT                   /note="Helical"
FT                   /evidence="ECO:0000269|PubMed:27296226,
FT                   ECO:0000269|PubMed:28878326"
FT   TOPO_DOM        617..767
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:27296226,
FT                   ECO:0000269|PubMed:28878326"
FT   REPEAT          84..114
FT                   /note="ANK 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          118..147
FT                   /note="ANK 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          156..185
FT                   /note="ANK 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          202..231
FT                   /note="ANK 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          235..276
FT                   /note="ANK 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          278..307
FT                   /note="ANK 6"
FT                   /evidence="ECO:0000255"
FT   REGION          1..33
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          133..143
FT                   /note="Interaction with calmodulin"
FT                   /evidence="ECO:0000250|UniProtKB:Q91WD2"
FT   REGION          637..641
FT                   /note="Interaction with S100A10"
FT                   /evidence="ECO:0000250|UniProtKB:Q91WD2"
FT   REGION          689..707
FT                   /note="Interaction with calmodulin"
FT                   /evidence="ECO:0000250|UniProtKB:Q91WD2"
FT   MOTIF           580..584
FT                   /note="Selectivity filter"
FT                   /evidence="ECO:0000269|PubMed:27296226"
FT   BINDING         581
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_note="ligand shared between two neighboring
FT                   subunits"
FT                   /evidence="ECO:0000269|PubMed:27296226,
FT                   ECO:0007744|PDB:5IWK, ECO:0007744|PDB:5IWP"
FT   MOD_RES         201
FT                   /note="Phosphotyrosine; by SRC"
FT                   /evidence="ECO:0000269|PubMed:17197020"
FT   MOD_RES         202
FT                   /note="Phosphotyrosine; by SRC"
FT                   /evidence="ECO:0000269|PubMed:17197020"
FT   CARBOHYD        397
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         201
FT                   /note="Y->F: Prevents up-regulation of the channel by
FT                   phosphorylation; when associated with F-202."
FT                   /evidence="ECO:0000269|PubMed:17197020"
FT   MUTAGEN         202
FT                   /note="Y->F: Prevents up-regulation of the channel by
FT                   phosphorylation; when associated with F-201."
FT                   /evidence="ECO:0000269|PubMed:17197020"
FT   MUTAGEN         535
FT                   /note="L->Q: Alters subunit assembly via domain swapping
FT                   and reduces channel activity."
FT                   /evidence="ECO:0000269|PubMed:28878326"
FT   HELIX           70..86
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           88..94
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           98..105
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   TURN            106..108
FT                   /evidence="ECO:0007829|PDB:5WO8"
FT   HELIX           122..128
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           132..141
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           143..146
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   TURN            154..157
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           160..166
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           170..178
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           190..192
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           206..212
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           216..224
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           239..244
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           249..261
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   STRAND          267..269
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   TURN            271..273
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           282..289
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           292..300
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   STRAND          303..309
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   STRAND          312..317
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   TURN            320..322
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   STRAND          323..326
FT                   /evidence="ECO:0007829|PDB:5WO8"
FT   TURN            327..329
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           331..337
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           341..346
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           352..361
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   TURN            362..364
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           365..387
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           397..399
FT                   /evidence="ECO:0007829|PDB:5IWK"
FT   TURN            401..404
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   TURN            418..420
FT                   /evidence="ECO:0007829|PDB:5WO6"
FT   HELIX           421..442
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           443..445
FT                   /evidence="ECO:0007829|PDB:6D7P"
FT   TURN            453..457
FT                   /evidence="ECO:0007829|PDB:6D7P"
FT   HELIX           463..481
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   TURN            482..484
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           487..489
FT                   /evidence="ECO:0007829|PDB:5IWK"
FT   HELIX           490..501
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           504..510
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   TURN            511..514
FT                   /evidence="ECO:0007829|PDB:6D7P"
FT   HELIX           515..530
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           533..552
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   TURN            556..558
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           565..576
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   STRAND          586..588
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   HELIX           592..613
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   TURN            614..617
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   TURN            618..620
FT                   /evidence="ECO:0007829|PDB:5IWK"
FT   HELIX           622..646
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   STRAND          649..652
FT                   /evidence="ECO:0007829|PDB:5WO6"
FT   STRAND          655..659
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   STRAND          662..664
FT                   /evidence="ECO:0007829|PDB:5WO7"
FT   STRAND          668..675
FT                   /evidence="ECO:0007829|PDB:5WO7"
SQ   SEQUENCE   767 AA;  87362 MW;  2197726C2F583720 CRC64;
     MGPLQREGRP ALGDANVAPG SSPGGVWHQP QPPKDSAFHP MGWSLPKEKG LILCLWNKFC
     RWFHRRESWA QSRDEQNLLQ QKRIWESPLL LAAKENNVQA LIKLLKFEGC EVHQKGAMGE
     TALHIAALYD NLEAAMVLME AAPELVFEPM TSELYEGQTA LHIAVINQNV NLVRALLARG
     ASVSARATGS VFHYRPHNLI YYGEHPLSFA ACVGSEEIVR LLIEHGADIR AQDSLGNTVL
     HILILQPNKT FACQMYNLLL SYDGGDHLKS LELVPNNQGL TPFKLAGVEG NIVMFQHLMQ
     KRKHIQWTYG PLTSTLYDLT EIDSSGDDQS LLELIVTTKK REARQILDQT PVKELVSLKW
     KRYGRPYFCV LGAIYVLYII CFTMCCVYRP LKPRITNRTN PRDNTLLQQK LLQEAYVTPK
     DDLRLVGELV SIVGAVIILL VEIPDIFRLG VTRFFGQTIL GGPFHVIIVT YAFMVLVTMV
     MRLTNSDGEV VPMSFALVLG WCNVMYFARG FQMLGPFTIM IQKMIFGDLM RFCWLMAVVI
     LGFASAFYII FQTEDPDELG HFYDYPMALF STFELFLTII DGPANYDVDL PFMYSITYAA
     FAIIATLLML NLLIAMMGDT HWRVAHERDE LWRAQVVATT VMLERKLPRC LWPRSGICGR
     EYGLGDRWFL RVEDRQDLNR QRIRRYAQAF QQQDDLYSED LEKDSGEKLE MARPFGAYLS
     FPTPSVSRST SRSSTNWDRL RQGALRKDLQ GIINRGLEDG EGWEYQI
//
